OptiNose (OPTN) Scheduled to Post Quarterly Earnings on Tuesday

OptiNose (NASDAQ:OPTN) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.05) per share for the quarter. OptiNose has set its FY 2024 guidance at EPS.

OptiNose (NASDAQ:OPTN) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.01. The company had revenue of $20.49 million for the quarter, compared to the consensus estimate of $20.81 million. On average, analysts expect OptiNose to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

OptiNose Price Performance

Shares of OptiNose stock opened at $0.68 on Wednesday. The business has a 50-day simple moving average of $0.80 and a 200 day simple moving average of $0.97. OptiNose has a one year low of $0.65 and a one year high of $2.10. The firm has a market capitalization of $102.83 million, a price-to-earnings ratio of -1.86 and a beta of -0.07.

About OptiNose

OptiNose, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device.